| DB ID | MyCo_5292 |
| Title | Serum procalcitonin levels in patients with primary pulmonary coccidioidomycosis |
| Year | 2014 |
| PMID | 25168059 |
| Fungal Diseases involved | Pulmonary coccidioidomycosis |
| Associated Medical Condition | None |
| Genus | Coccidioides |
| Species | posadasii |
| Organism | Coccidioides posadasii |
| Ethical Statement | This study was approved by the Mayo Clinic Institutional Review Board. |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | PCT |
| Biomarker Full Name | Procalcitonin |
| Biomarker Type | Negative |
| Biomolecule | Gene |
| Geographical Location | Arizona |
| Cohort | Here identified and enrolled 20 immunocompetent patients with symptomatic primary pulmonary coccidioidomycosis of , 8 weeks’ duration and performed a one-time procalcitonin assay, with a cutoff of , 0.25 mg/L indicating a nonbacterial infection. |
| Cohort No. | 20 |
| Age Group | 62 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | CT scan |
| Analysis Method | mini- VIDAS BRAHMS PCT (bioM´ erieux Inc., Durham, NC) assay |
| ELISA kits | None |
| Assay Data | FDA- mini-VIDAS BRAHMS PCT (bioM´ erieux Inc.,Durham, NC) assay on the miniVIDAS |
| Validation Techniques used | mini- VIDAS BRAHMS PCT (bioM´ erieux Inc., Durham, NC) assay |
| Up Regulation Down Regulation | Negative |
| Sequence Data | None |
| External Link | None |
